Corneal avascularity is due to soluble VEGF receptor-1

Nature

Volumn 443, Issue 7114, 2006, Pages 993-997

  Ambati, Balamurali K ^a   Nozaki, Miho ^b   Singh, Nirbhai ^a   Takeda, Atsunobu ^b   Jani, Pooja D ^a   Suthar, Tushar ^a   Albuquerque, Romulo J C ^b   Richter, Elizabeth ^a   Sakurai, Eiji ^b,c   Newcomb, Michael T ^b   Kleinman, Mark E ^b   Caldwell, Ruth B ^a   Lin, Qing ^d   Ogura, Yuichiro ^c   Orecchia, Angela ^e   Samuelson, Don A ^f   Agnew, Dalen W ^g,r   St Leger, Judy ^h   Green, W Richard ⁱ   Mahasreshti, Parameshwar J ^j   Curiel, David T ^j   Kwan, Donna ^k   Marsh, Helene ^k   Ikeda, Sakae ^l   Leiper, Lucy J ^m   Collinson, J Martin ^m   Bogdanovich, Sasha ⁿ   Khurana, Tejvir S ⁿ   Shibuya, Masabumi ^o   Baldwin, Megan E ^p   Ferrara, Napoleone ^p   Gerber, Hans Peter ^h,p   De Falco, Sandro ^q   Witta, Jassir ^b   Baffi, Judit Z ^b   Raisler, Brian J ^b   Ambati, Jayakrishna ^b   more..

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^f Scott)   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Molecular and Cell Biology Laboratory IDI IRCCS ^*  (United States)

ⁱ JOHNS HOPKINS UNIVERSITY   (United States)

^j University of Alabama at Birmingham   (United States)

^k JAMES COOK UNIVERSITY   (Australia)

^l UNIVERSITY OF WISCONSIN MADISON   (United States)

^m UNIVERSITY OF ABERDEEN   (United Kingdom)

ⁿ UNIVERSITY OF PENNSYLVANIA   (United States)

^o UNIVERSITY OF TOKYO   (Japan)

^p GENENTECH INC   (United States)

^q INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^r MICHIGAN STATE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH KINETICS; IMMUNOLOGY; MARINE BIOLOGY; MOLECULAR BIOLOGY; OPTICAL PROPERTIES; TISSUE;

CORNEA; MARINE MAMMALS; OPTICAL CLARITY; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

BLOOD VESSELS;

VASCULOTROPIN RECEPTOR 1;

BLOOD; GROWTH RATE; MOLECULAR ANALYSIS; OPTICAL PROPERTY; PHENOTYPE; PHYLOGENETICS; RNA; VISION;

ANGIOGENESIS; ANIRIDIA; ARTICLE; BLOOD VESSEL; CORNEA; CORNEA DISEASE; CORNEA NEOVASCULARIZATION; DUGONG; ELEPHANT; GENE DISRUPTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIRENIA;

CETACEA; ELEPHANTIDAE; MAMMALIA; SIRENIA; TRICHECHIDAE;

EID: 33750430869     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05249     Document Type: Article

References (30)

1. Sharma, P. V. Susruta-Samhita (Chaukhambha Visvabharati, Varanasi, India, 2001).
2. Magnus, H. Ophthalmology of the Ancients (J. P. Wayenborgh, Oostende, Belgium, 1999).
3. Meyer, K. & Chaffee, E. The mucopolysaccharide acid of the cornea and its enzymatic hydrolysis. Am. J. Ophthalmol. 23, 1320-1325 (1940).
4. Gimbrone, M. A. Jr, Cotran, R. S., Leapman, S. B. & Folkman, J. Tumor growth and neovascularization: an experimental model using the rabbit cornea. J. Natl Cancer Inst. 52, 413-427 (1974).
5. Chang, J. H., Gabison, E. E., Kato, T. & Azar, D. T. Corneal neovascularization. Curr. Opin. Ophthalmol. 12, 242-249 (2001).
6. Wiegand, S. J. et al. Genetic modulation of pigment epithelium-derived factor (PEDF) expression does not alter normal or pathological angiogenesis in the eye, or tumor growth. Invest. Ophthalmol. Vis. Sci. 45, abstr. 1884 (2004).
7. Cursiefen, C. et al. Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. Invest. Ophthalmol. Vis. Sci. 45, 1117-1124 (2004).
8. Bugge, T., Flick, M., Daugherty, C. & Degen, J. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev. 9, 794-807 (1995).
9. Fukai, N. et al. Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J. 21, 1535-1544 (2002).
10. Hirsch, E., Irikura, V. M., Paul, S. M. & Hirsh, D. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc. Natl Acad. Sci. USA 93, 11008-11013 (1996).
11. Kendall, R. L. & Thomas, K. A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl Acad. Sci. USA 90, 10705-10709 (1993).
12. Smith, R. et al. Corn1: a mouse model for corneal surface disease and neovascularization. Invest. Ophthalmol. Vis. Sci. 37, 397-404 (1996).
13. +/- small eye mice mimic human aniridia-related keratopathy. Invest. Ophthalmol. Vis. Sci. 44, 1871-1878 (2003).
14. Jordan, T. et al. The human PAX6 gene is mutated in two patients with aniridia. Nature Genet. 1, 328-332 (1992).
15. Harper, J. Y., Samuelson, D. A. & Reep, R. L. Corneal vascularization in the Florida manatee (Trichechus manatus latirostris) and three-dimensional reconstruction of vessels. Vet. Ophthalmol. 8, 89-99 (2005).
16. Hiratsuka, S., Minowa, O., Kuno, J., Noda, T. & Shibuya, M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl Acad. Sci. USA 95, 9349-9354 (1998).
17. Fong, G. H., Rossant, J., Gertsenstein, M. & Breitman, M. L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70 (1995).
18. Stechschulte, S. U. et al. Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest. Ophthalmol. Vis. Sci. 42, 1975-1979 (2001).
19. Lin, Q., Jo, D., Gebre-Amlak, K. D. & Ruley, H. E. Enhanced cell-permeant Cre protein for site-specific recombination in cultured cells. BMC Biotechnol. 4, 25 (2004).
20. Jo, D. et al. Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nature Biotechnol. 19, 929-933 (2001).
21. Hiratsuka, S. et al. Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice. Mol. Cell. Biol. 25, 346-354 (2005).
22. Gerber, H. P., Condorelli, F., Park, J. & Ferrara, N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J. Biol. Chem. 272, 23659-23667 (1997).
23. Ikeda, S. et al. Aberrant actin cytoskeleton leads to accelerated proliferation of corneal epithelial cells in mice deficient for destrin (actin depolymerizing factor). Hum. Mol. Genet. 12, 1029-1036 (2003).
24. Ambati, B. K. et al. Sustained inhibition of corneal neovascularization by genetic ablation of CCR5. Invest. Ophthalmol. Vis. Sci. 44, 590-593 (2003).
25. Ambati, B. K., Joussen, A. M., Kuziel, W. A., Adamis, A. P. & Ambati, J. Inhibition of corneal neovascularization by genetic ablation of CCR2. Cornea 22, 465-467 (2003).
26. Graubert, M. D., Ortega, M. A., Kessel, B., Mortola, J. F. & Iruela-Arispe, M. L. Vascular repair after menstruation involves regulation of vascular endothelial growth factor-receptor phosphorylation by sFLT-1. Am. J. Pathol. 158, 1399-1410 (2001).
27. Kearney, J. B., Kappas, N. C., Ellerstrom, C., DiPaola, F. W. & Bautch, V. L. The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis. Blood 103, 4527-4535 (2004).
28. Levine, R. J. et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672-683 (2004).
29. Bergers, G. et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biol. 2, 737-744 (2000).
30. Dana, M. R. & Streilein, J. W. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 37, 2485-2494 (1996).